Simplifying Global Compliance
Industry Advises No FDA Regulation for Some mHealth Devices
Devices & Diagnostics Letter
An industry group is advising the FDA to not regulate certain mobile health (mHealth) products, which can include medical smart phone applications, because their “social benefit” outweighs their inherent low risk.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing